Presence of detrusor muscle in bladder tumor specimens-predictors and effect on outcome as a measure of resection quality

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 1, 2014, Pages 40.e17-40.e22

  Shoshany, Ohad ^a,b   Mano, Roy ^a,b   Margel, David ^a,b   Baniel, Jack ^a,b   Yossepowitch, Ofer ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Bladder cancer; Detrusor muscle; Histology; Surgical quality; Transurethral resection

Indexed keywords

AGED; ARTICLE; BLADDER TUMOR; CANCER PROGNOSIS; CANCER STAGING; CORRELATION ANALYSIS; DETRUSOR MUSCLE; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; RISK; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

BLADDER CANCER; DETRUSOR MUSCLE; HISTOLOGY; SURGICAL QUALITY; TRANSURETHRAL RESECTION;

AGED; AGED, 80 AND OVER; CYSTECTOMY; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLE, SMOOTH; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ODDS RATIO; PROGNOSIS; TREATMENT OUTCOME; TUMOR BURDEN; URINARY BLADDER NEOPLASMS;

EID: 84890805167     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2013.04.009     Document Type: Article

References (16)

1. Maruniak N.A., Takezawa K., Murphy W.M. Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling. J Urol 2002, 167:2404-2407.
2. Pan D., Soloway M.S. The importance of transurethral resection in managing patients with urothelial cancer in the bladder: proposal for a transurethral resection of bladder tumor checklist. Eur Urol 2012, 61:1199-1203.
3. Birido N., Geraghty J.G. Quality control in breast cancer surgery. Eur J Surg Oncol 2005, 31:577-586.
4. Dikken J.L., Cats A., Verheij M., van de Velde C.J. Randomized trials and quality assurance in gastric cancer surgery. J Surg Oncol 2012, 107:298-305.
5. Vickers A., Savage C., Bianco F., et al. Cancer control and functional outcomes after radical prostatectomy as markers of surgical quality: analysis of heterogeneity between surgeons at a single cancer center. Eur Urol 2011, 59:317-322.
6. Raj G.V., Bochner B.H. Radical cystectomy and lymphadenectomy for invasive bladder cancer: towards the evolution of an optimal surgical standard. Semin Oncol 2007, 34:110-121.
7. Mariappan P., Zachou A., Grigor K.M. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol 2009, 57:843-849.
8. Herr H.W., Donat S.M. Quality control in transurethral resection of bladder tumours. BJU Int 2008, 102:1242-1246.
9. Divrik R.T., Yildirim U., Zorlu F., Ozen H. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J Urol 2006, 175:1641-1644.
10. Grimm M.O., Steinhoff C., Simon X., Spiegelhalder P., Ackermann R., Vogeli T.A. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 2003, 170:433-437.
11. Dalbagni G., Herr H.W., Reuter V.E. Impact of a second transurethral resection on the staging of T1 bladder cancer. Urology 2002, 60:822-824. [discussion 4-5].
12. Cina S.J., Epstein J.I., Endrizzi J.M., Harmon W.J., Seay T.M., Schoenberg M.P. Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder. Hum Pathol 2001, 32:630-637.
13. Herr H.W., Al-Ahmadie H., Dalbagni G., Reuter V.E. Bladder cancer in cystoscopically normal-appearing mucosa: a case of mistaken identity?. BJU Int 2010, 106:1499-1501.
14. Herr H.W., Donat S.M., Dalbagni G. Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder. J Urol 2002, 168:978-980.
15. Herr H.W., Donat S.M. Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopy. BJU Int 2011, 107:396-398.
16. Witjes J.A., Redorta J.P., Jacqmin D., et al. Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations. Eur Urol 2010, 57:607-614.